Skip to main content
PFE
NYSE Life Sciences

Pfizer Sells Minipress India Rights to Novartis for ₹1,250 Crore, Discontinues Sales

Tom Rudovsky · Reported by CNBC TV18
More coverage: Pharmaceutical Stocks · Healthcare
Sentiment info
Neutral
Importance info
7
Price
$28.44
Mkt Cap
$162.156B
52W Low
$23.58
52W High
$29.21
52W Position info
21% above low
Off High info
2.6% below high
Rel. Volume info
0.6× avg
Market data snapshot near publication time

PFE sits 21% above its 52-week low of $23.58.

Summary

Pfizer is divesting its Minipress hypertension drug in India, selling the trademarks and related IP to Novartis India for ₹1,250 crore (~$150M). Simultaneously, Pfizer will discontinue marketing and distribution of Minipress XL in India effective September 7, 2026, and its Indian subsidiary will receive a $13.9 million lump-sum payment from the parent. The drug generated ₹228.6 crore in revenue with 6.3% CAGR, so the sale represents a modest but clean exit from a non-core market. This follows Pfizer's Q2 2026 net loss and $2.5B cost-savings program, aligning with its portfolio streamlining. The transaction is not related-party and closes immediately upon signing.

At the time of this announcement, PFE was trading at $28.44 on NYSE in the Life Sciences sector, with a market capitalization of approximately $162.2B. The 52-week trading range was $23.58 to $29.21. This news item was assessed with neutral market sentiment and an importance score of 7 out of 10. Source: CNBC TV18.


Price Chart

Share this article

Copied!

PFE - Latest Insights

PFE
Nov 18, 2026, 7:20 AM EST
Source: Dow Jones Newswires
Importance Score:
7
Price at Filing: $28.28
Real-time Price: $27.44 info
Change: -$0.840 (-3%) info
Market Cap: $156.176B info
PFE
Nov 16, 2026, 6:00 AM EST
Source: Wiseek News
Importance Score:
7
Price at Filing: $29.12
Real-time Price: $27.44 info
Change: -$1.68 (-6%) info
Market Cap: $156.176B info
PFE
Nov 13, 2026, 3:19 PM EST
Source: Reuters
Importance Score:
7
Price at Filing: $28.85
Real-time Price: $27.44 info
Change: -$1.41 (-5%) info
Market Cap: $156.176B info
PFE
Nov 11, 2026, 4:30 PM EST
Source: BusinessWire
Importance Score:
7
Price at Filing: $29.45
Real-time Price: $27.44 info
Change: -$2.01 (-7%) info
Market Cap: $156.176B info
PFE
Nov 03, 2026, 8:19 AM EST
Filing Type: 10-Q
Importance Score:
8
Price at Filing: $30.66
Real-time Price: $27.44 info
Change: -$3.22 (-11%) info
Market Cap: $156.176B info